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Recent genome-wide studies have revealed the presence of thousands of long non-
protein-coding RNAs (lncRNAs), some of which may play critical roles in the cell. We have
previously shown that a large number of lncRNAs show differential expression in response
to interferon (IFN)α stimulation in primary human cells. Here, we show that a subset of
IFN-induced lncRNAs are positioned in proximity of protein-coding IFN-stimulated genes
(ISGs).The majority of gene pairs originated from bidirectional promoters and showed pos-
itively correlated expression. We focused our analysis on a pair consisting of the known
protein-coding ISG, BST2, and an un-studied putative lncRNA originating from the pro-
moter region of BST2 in a divergent orientation. We showed that this transcript was a
multi-exonic, polyadenylated long RNA that lacked protein-coding capacity. BST2 and the
lncRNA were both induced in response to IFNα in diverse cell types. The induction of
both genes was mediated through the JAK–STAT pathway, suggesting that IFN-stimulated
response elements within the shared promoter activated the transcription of both genes.
RNAi-mediated knock-down of the lncRNA resulted in down-regulation of BST2, and we
could show that this down-regulation occurred at the level of transcription. Forced overex-
pression of this lncRNA, which we named BST2 IFN-Stimulated Positive Regulator (BISPR),
resulted in up-regulation of BST2, indicating that the regulation of expression of BST2 by
BISPR is mediated through interactions involving BISPR RNA itself, rather than the impact
of its transcription from an adjacent locus. Importantly, upon IFN stimulation, transcrip-
tional activation of BISPR preceded the induction of BST2, suggesting that expression of
BISPR facilitated the initiation of transcription in its paired protein-coding gene.The lncRNA-
mediated transcriptional regulation described in this study may help govern the expression
of additional protein-coding RNAs involved in IFN response and other cellular processes.
Keywords: lncRNAs, bidirectional promoters, BST2, transcriptional regulation, IFN response
INTRODUCTION
The interferon (IFN) response is a critical arm of innate immunity
and constitutes a major host defense mechanism against inva-
sion of pathogens such as viruses and bacteria (1–3). Release
of IFNs, which mainly occurs in response to viral and micro-
bial encounter, results in signaling through the IFN receptors,
which in turn leads to activation of the JAK–STAT pathway (2–
4). The final outcome of this signaling pathway is the formation
of a transcriptional activator complex between phosphorylated
STAT1, STAT2, and the transcription factor Interferon Regula-
tory Factor 9 (IRF9). The STAT1/STAT2/IRF9 ternary complex
binds to the IFN-stimulated response elements (ISREs) found in
promoter of IFN-responsive genes, resulting in up-regulation of
expression of a large number of host genes. While the function
of many IFN-stimulated genes (ISGs) remains un-studied, analy-
sis of a subset of them has indicated their involvement in various
aspects of antiviral defense and immune modulatory functions
(1–4).
Recent large scale transcriptome analyses have revealed the
existence of tens of thousands of long non-protein-coding RNAs
(lncRNAs), which play crucial roles in diverse aspects of cellu-
lar function including several steps in both innate and adaptive
immune responses (5–14). However, the role of this class of tran-
scripts in the IFN response had not been investigated. Recently,
using a high-throughput RNA sequencing approach on IFN-
stimulated primary human cells, we provided evidence for the
presence of tens of lncRNAs which showed a robust transcriptional
up-regulation in response to IFN (15). Analysis of the function of
one of the upregulated lncRNAs, Negative Regulator of the IFN
Response (NRIR, originally named lncRNA-CMPK2), proved that
it was a negative regulator of the IFN response and functioned as a
transcriptional repressor of a subset of protein-coding ISGs (15).
While the function of all the other identified IFN-induced lncR-
NAs remain unknown, it is likely that similar to NRIR, many of
them perform important roles as regulators or effector molecules
in the IFN response.
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Current studies of the function of lncRNAs indicate that many
of them regulate the expression of other genes through diverse
mechanisms including induction of changes in the structure of
chromatin and recruitment of various effector molecules such as
transcriptional complexes, or direct interactions with other RNAs
such as miRNAs or protein-coding RNAs (6, 7, 16–19). In many
cases, lncRNAs seem to regulate the expression of protein-coding
or other lncRNA genes which are located in their vicinity and
thus, analysis of the genomic locus of lncRNAs and their relative
positioning compared to the nearby genes can provide important
clues into their function (7, 16, 20). For example, overlap of the
locus of a lncRNA with the promoter region of another gene can
result in interference with the formation of transcriptional com-
plexes on the promoter of the overlapped gene by run-through
transcription, or alternatively make it accessible to transcriptional
complexes. Even in the absence of overlap, a nearby lncRNA gene
can affect the expression of nearby genes in a positive or negative
manner, for example by binding and increasing the local concen-
tration of effector molecules such as chromatin modifying factors,
resulting in local modulation of chromatin structure. The impact
of lncRNA transcription on expression of protein-coding genes is
particularly important as it has been shown that promoters are
inherently bidirectional, and a large fraction of human protein-
coding genes have a non-coding transcript originating from their
promoters in the opposite direction (21–25). While the majority
of such promoter-upstream transcription results in short, unsta-
ble RNAs, in a subset of genes it results in stable, longer RNAs that
in many cases are spliced and polyadenylated (26–28). The pres-
ence of such “bidirectional” promoters generating coordinately
expressed pairs of protein-coding genes has been known for over a
decade (21, 22, 29). In many cases, the paired genes perform related
functions and thus, their transcription from the same promoter
facilitates their coordinated expression (22, 29). More recent dis-
covery of the origination of protein-coding/lncRNA pairs from
bidirectional promoters has raised the intriguing possibility that
the pairs may similarly perform related functions or that the lncR-
NAs may regulate the expression of their paired protein-coding
genes through the mechanisms described above and elsewhere
in literature (5, 25, 27). While the global analysis of protein-
coding/lncRNA pairs originating from bidirectional promoters
has indicated that the majority of them show coordinated expres-
sion, some pairs are expressed in a mutually exclusive fashion,
suggesting that a diversity of regulatory mechanisms can be at
work in such loci (23, 25, 27, 30). Functional study of a small
number of these promoters has confirmed this point, as knock
down experiments on one of the two transcripts in such pairs has
resulted in both up- and down-regulation of the other member
of the pair, suggesting that such paired RNAs may engage in com-
plex regulatory interactions (30–32). Considering the abundance
of protein-coding/lncRNA pairs originating from bidirectional
promoters, it is likely that these regulatory interactions play a
prominent role in the overall control of gene expression.
As a first step toward understanding the role of protein-
coding/lncRNA pairs in regulation of the IFN response, we iden-
tified lncRNA and protein-coding RNAs which were located
in proximity of each other and showed differential expression
in response to IFN stimulation. All identified pairs showed a
correlated transcriptional response to IFN, and included a number
of known protein-coding ISGs. Functional analysis of one such loci
indicated the presence of a stable, spliced, and polyadenylated long
non-coding RNA resulting from apparent bidirectional transcrip-
tion from the BST2 (Tetherin) promoter. The expression of the
lncRNA in response to IFN was mediated through the JAK–STAT
pathway and correlated with the expression of BST2 in diverse
cell types. Interestingly, forced overexpression and knock down
of the lncRNA resulted in an increase and decrease in expression
of BST2, respectively, suggesting that the expression of lncRNA,
which we name BST2 IFN-stimulated positive regulator (BISPR),
was needed for efficient transcription of its paired protein-coding
gene. We could show that this regulation was at the level of tran-
scription, and importantly, that upon IFN stimulation, the rise in
the level of BISPR preceded the induction of BST2, suggesting that
the transcription of BISPR facilitated the initiation of transcrip-
tion in its paired protein-coding gene. Intriguingly, the putative
bidirectional promoter giving rise to BISPR and BST2 overlaps an
enhancer, raising the possibility that both RNAs may have evolved
from enhancer-associated (eRNA) transcripts.
MATERIALS AND METHODS
COMPUTATIONAL ANALYSES
The paired-end 100 bp-long RNA-seq reads that formed the basis
for this study originated from high-throughput transcriptome
analysis of human primary hepatocytes obtained from five human
donors (SRA accession number SRP045406) (15). Data were
processed and analyzed as described (15). Protein-coding and
non-coding genes that showed robust expression and significant
IFN-mediated differential expression of over twofold in either
direction were filtered for being in proximity of each other (defined
by the maximum distance of<2000 bp between the two transcrip-
tional units). The naming of novel transcripts was according to
HGNC guidelines (33). Defining the open reading frames (ORFs)
was performed as described (15). Statistical studies for deter-
mining the Spearman’s correlation coefficient in Figure 5E was
performed as previously described (34).
CELL CULTURE EXPERIMENTS
Cell lines used in this study were kind gifts of Drs. Karn, Rice, and
Dowlati (15). Primary human keratinocytes were obtained from
neonatal foreskin and were passaged twice before being studied.
For primary keratinocytes and natural killer (NK) and periph-
eral blood mononuclear cells (PBMC), subjects provided written
informed consent for the use of their blood (for NK and PBMC
cells) or foreskin (for primary keratinocytes) cells. The samples
were obtained according to the guidelines of the 1975 Declara-
tion of Helsinki with prior approval of the institutional review
board for human studies at University Hospitals of Cleveland.
The harvest of primary NK and PBMC cells from healthy donors
was performed as previously described (35). The RNA from cells
derived from individual donors was extracted and analyzed by
RT-qPCR as described below. All cells were cultured at 37°C
in a humidified atmosphere at 5% CO2 as described previously
(15). Primary keratinocytes were cultured in keratinocyte-specific
serum-free medium (Gibco 2015-16) supplemented by 5 ng/ml
human recombinant EGF and 50µg/ml bovine pituitary extract
Frontiers in Immunology | Molecular Innate Immunity January 2015 | Volume 5 | Article 676 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kambara et al. lncRNA-mediated regulation of BST2 expression
(Gibco 2015-10). Treatment of cells with IFNα, ruxolitinib, actino-
mycin D, IFNγ, and TNFα, and extraction of total cellular RNA was
performed as described (15). Cellular fractionation into nuclear
and cytoplasmic fractions was performed as previously described
(34). 5′ and 3′ RACE (rapid amplification of cDNA ends) was
performed using SMARTer RACE cDNA amplification kit from
Clontech, as described (15).
POLYSOME PROFILE ANALYSIS
To investigate the association of BISPR with the translational
machinery, we used human corneal epithelial cells, which showed
a robust expression of BISPR and BST2 and allowed for unam-
biguous identification and quantitation of the RNAs in differ-
ent polysome fractions. The 10.014 pRSVT cells (ATCC® CRL-
11515™) were incubated with 100µg/ml cycloheximide for 5 min
before harvesting. Cells were lysed in polysome lysis buffer (10 mM
HEPES-KOH, pH 7.4, 7.5 mM MgCl2, 100 mM KCl, 1 mM dithio-
threitol, 0.25% Non-idet P-40, 200 units/ml RNase inhibitor,
100µg/ml cycloheximide, and one tablet of EDTA-free protease
inhibitor mixture/10 ml (Roche Applied Science)] and homoge-
nized by passing the lysate through a 23G needle 15 times. Lysates
were centrifuged at 17,000× g for 10 min; the supernatants were
collected, and absorbance was measured. About seven A254 units
of the cytosolic extracts were layered over 10–50% sucrose gradi-
ents and centrifuged at 17,000 rpm in a Beckman SW28 rotor for
15 h at 4°C. After centrifugation, fractions (~1.2 ml each) were col-
lected. RNA was extracted with TRIzol reagent (Invitrogen) and
used to determine the distribution of ribosomal RNAs (by agarose
gel electrophoresis) and BISPR, BST2, and GAPDH transcripts (by
RT-qPCR).
RT-PCR
Preparation of cDNA was performed as described, using both oligo
(dT) and random hexamers (15). For strand-specific RT-qPCR,
the indicated reverse transcription primers were used in the RT
reaction, followed by inactivation of the RT enzyme. The resulting
cDNA was used in qPCR reactions with Biorad SYBR Green Kit
(Biorad) on a Mastercycler Realplex2 system (Eppendorf) and ana-
lyzed as described (15). Error bars represent the SEM from at least
two technical repeats and two biological repeats per experiment.
To determine the statistical significance of observed differences, p-
values were calculated using Student’s t -test with p-values <0.05
considered significant.
GENE SILENCING
Knock-down of STAT2 was performed as previously described
(15). Dicer-substrate interference RNAs (DsiRNAs) targeting
BISPR and negative control DsiRNAs were purchased from Inte-
grated DNA Technologies (DsiRNA#1 sense: GACACACAGAGU
AUCCUUAACCCAC, antisense: GUGGGUUAAGGAUACUCUG
UGUGUCUU, which target nucleotides 670–694 of BISPR close
to the 5′ end of the last exon; DsiRNA#2 sense: CACUUAGGCAG
GAGGAUCACUCGAG, antisense: CUCGAGUGAUCCUCCUGC
CUAAGUGUU, which target nucleotides 546–570 of BISPR close
to the 3′ end of the third exon). THP1 cells were seeded onto
six-well plates and transfected with 20 nM final concentration of
DsiRNAs using Lipofectamine ® RNAiMax Reagent (Invitrogen)
according to the manufacturer’s protocol. The transfected cells
were incubated for 24 h in RPMI 1640 supplemented with 10%
FBS and used for the downstream experiments. EZH2 knock down
studies were performed on THP1 cells using shRNA constructs
TRCN0000040074 and TRCN0000040077 targeting EZH2 and the
non-targeting SHC002 shRNA construct from Sigma. Lentiviral
preparation, cell transfection, and RNA harvest was performed as
described (15).
RESULTS
To investigate the extent of lncRNA-mediated regulation of nearby
protein-coding genes in the IFN response, we took advantage of
a high-throughput transcriptome analysis dataset that we had
generated using IFN-treated human primary hepatocytes (15).
We analyzed the dataset for pairs of protein-coding and non-
coding genes that were located within 2 kb of each other and
showed robust differential expression in response to IFNα treat-
ment. Using the GENCODE v19 database of putative annotated
lncRNAs, we identified nine lncRNA/protein-coding RNA pairs
that satisfied these criteria (Figure 1A, Table S1 in Supplemen-
tary Material). We also analyzed the data for the presence of novel
transcripts that changed expression in response to IFNα and were
located in proximity of an IFN-responsive protein-coding gene.
We identified two previously unannotated, long transcripts that
met our criteria (Figure 1A, RNAs with double asterisks, Table
S1 in Supplementary Material). Except two RNAs, which were
intronic or positioned in tandem with their protein-coding part-
ner [USP18-IT1 and NRIR/lncRNA-CMPK2 (15), respectively],
the other identified transcripts were positioned in a head-to-
head, divergent manner compared to their paired protein-coding
genes and likely originated from bidirectional promoters (Table
S1 in Supplementary Material). Interestingly, one of the identi-
fied protein-coding genes was BST2 (Tetherin), which codes for a
known IFN-induced protein that blocks the release of enveloped
viral particles from infected cells (36–39). In addition to its role
as an effector of the IFN-induced antiviral response, it also has
roles in negative feedback regulation of IFN production and other
immunomodulatory effects (36–40). BST2 was positioned in a
head-to-head divergent orientation with an annotated, previously
un-studied putative lncRNA, which we named BISPR (see below)
(Figure 1B). Similar to the majority of previously described gene
pairs originating from putative bidirectional promoters, BST2 and
BISPR, together with the rest of gene pairs identified in this study,
showed concordant expression in response to IFN stimulation
(Figure 1A) (21, 22). The annotated transcription start site (TSS)
of BST2 and BISPR were ~250 bp apart, similar to the distance
reported for most bidirectionally transcribed gene pairs (22, 30)
(Figure 1B).
COORDINATED EXPRESSION OF BST2 AND BISPR FROM A
BIDIRECTIONAL PROMOTER
We analyzed the sequence of the putative bidirectional promoter
of BST2 and BISPR. Similar to the majority of other bidirec-
tional promoters, it lacks a TATA box, but has a CCAAT pro-
moter element (Figure 1B) (29, 30). Analysis of the ChIP-seq
data available in public databases provided evidence for associa-
tion of CCAAT-binding proteins NF-YA, NF-YB, and CEBPB, and
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FIGURE 1 | Interferon-induced lncRNA/protein-coding RNA pairs show
coordinated expression. (A) Coordinated expression pattern of ten
lncRNA/protein-coding RNA pairs. One of the protein-coding RNAs has two
concordantly expressed, neighboring lncRNAs. Each pair is separated from
the other genes by a white line. The numbers on top indicate hours after the
addition of IFNα. The names of genes are shown to the right, with genes
named in this study marked by an asterisk. Genes with two asterisks are
novel, previously unannotated transcripts. (B)The locus of BST2/BISPR. The
direction of transcription and name of each gene is shown on top. Exons are
shown as solid gray (BST2 and MVB12A) and black (BISPR) rectangles, with
introns represented as thin broken lines. The numbers at the bottom of
introns and exons indicate size in nucleotides. The distance between the two
transcription start sites are shown and the position of important elements are
marked. Single-headed arrows on top of exons 2 and 3 of BISPR mark the site
of PCR primers used in the majority of the studies described in this work.
(C) Schematic representation of the density of RNA-seq reads mapping to the
BISPR locus. The intron/exon structure of BISPR is shown on top. Numbers at
the bottom indicate the position of the locus on chromosome 19. Numbers to
the left refer to the time point after the addition of IFNα at which the sample
was taken for high-throughput transcriptome analysis. (D) Strand-specific
RT-PCR confirms the divergent orientation of BISPR and BST2 transcription.
F and R refer to forward or reverse primers (relative to the direction of
transcription of the analyzed gene). The identity of the primers that were used
in reverse transcription reactions are shown below each lane. The large
numbers on the Y axis reflect the very low basal expression level of the two
RNAs.
additional transcriptional regulatory factors frequently found to
bind to bidirectional promoters such as YY1, c-Myc, NFkB, MAX,
and GATA3 (Figure S1 in Supplementary Material) (29, 30, 41).
Unlike most reported bidirectional promoters, the BST2-BISPR
promoter lacks CpG islands, however, it has been shown that
bidirectional promoters use a variety of core promoter elements
and are not necessarily dependent on CpG islands for promoter
function (42). We also analyzed the sequence of BISPR for decay-
inducing and stabilizing elements. It has been shown that the
vast majority of transcripts resulting from bidirectional promoter
transcription are short, unstable transcripts, which are commit-
ted to decay due to the early occurrence of polyadenylation signal
motifs (AWTAAA, where W is either A or T) and the absence of
stabilizing U1 snRNA-binding sequences (43, 44). While BISPR
lacked AWTAAA motifs in its first ~1000 nt, it had multiple copies
of U1-binding sequences and splicing events occurring in its first
500 bases, which explained its stability. Most interestingly, the
shared promoter region of BST2 and BISPR falls within overlap-
ping H3K4me1, H3K4me3, and H3K27ac histone modification
marks, which are characteristic of transcribed, active enhancers
(Figure S1 in Supplementary Material) (24, 45).
Consistent with the induction of expression of BST2 and BISPR
in response to IFN stimulation, the putative bidirectional pro-
moter contains an ISRE element and ChIP data in public databases
showed the binding of STAT1 and STAT2 proteins to this region
(Figure 1B and Figure S1 in Supplementary Material). Analysis
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FIGURE 2 | BST2 IFN-stimulated positive regulator is a
polyadenylated RNA and shows concordant expression with
BST2. (A–C) RT-qPCR assays show the extent of induction of BISPR,
BST2, and MVB12A in response to IFNα stimulation. The identity of
the RNA analyzed in each panel is shown on top. The large numbers at
the Y axis of A and B reflect the very low basal expression level of the
RNAs. (D) BISPR and BST2 are polyadenylated RNAs. Plus and minus
signs indicate the presence or absence of the shown ingredients in
the cell culture medium or reverse transcription reactions prior to
qPCR assays.
of the RNA-seq data in publicly available databases provided evi-
dence for concordant transcription in BST2 and BISPR loci (Figure
S1 in Supplementary Material), similar to what we had observed
in our RNA-seq analysis. Pattern of RNA-seq reads at the locus of
BISPR indicated the presence of an efficiently spliced, multi-exonic
transcript with four exons and three introns (Figures 1B,C and
Figure S1 in Supplementary Material). To confirm the presence of
this transcript, we performed strand-specific RT-PCR assays using
primers that flanked an exon–exon junction and thus, could only
detect spliced, fully mature transcripts (Figure 1B, single-headed
arrows). We observed evidence for the presence of an IFN-induced
transcript in the expected orientation, while no RNA could be
detected originating from the opposite strand (Figure 1D). As
a control, we performed an identical analysis on BST2, which
showed the presence of an IFN-induced transcript in the annotated
locus of BST2 in opposite orientation to BISPR (Figure 1D). We
further confirmed the IFN-induced expression pattern of BISPR
and BST2 in Huh7.5 hepatocytes, which showed an overall similar
pattern of IFN-mediated time course of transcriptional induction
between BST2 and BISPR (Figures 2A,B). In contrast, the expres-
sion of MVB12A gene, which is located in proximity of BISPR
(Figure 1B) did not show a significant induction (Figure 2C).
BISPR IS A SPLICED AND POLYADENYLATED LONG NON-CODING RNA
We could show that BISPR, similar to BST2, is a polyadenylated
message (Figure 2D) and confirmed the presence and location of
the splice junctions by sequencing its cDNA (data not shown).
Next, we determined the ends of the mature BISPR transcript
using 5′ and 3′ RACE assays (Figures S2, S3 in Supplementary
Material), which showed minor differences at TSS and 3′ cleavage
sites compared to the annotations in public databases. Phyloge-
netic analysis indicated that the region between the TSS of BST2
and BISPR and the first two exons and parts of the last exon
of BISPR were conserved among mammals, with the third exon
of BISPR only showing conservation among primates (Figure S4
in Supplementary Material). We analyzed the subcellular local-
ization of BISPR, which showed that in the absence of IFN it
was predominantly nuclear, while after IFN induction the RNA
was present in both compartments (Figures 3A–C). To deter-
mine if BISPR had any protein-coding capacity, we analyzed the
sequence of the RNA for the presence of ORFs, which showed
the presence of five potential ORFs that were between 36 and
49 amino acids in length (Figure S5 in Supplementary Material).
The position of ORFs within BISPR was not conducive to effi-
cient translation, as they either ended before the last exon–exon
junction or had upstream ORFs, which will result in activation of
NMD-mediated decay pathways if the RNA is subjected to transla-
tion (Figure S5 in Supplementary Material). We further analyzed
the sequence of the ORFs for potential protein-coding capacity.
Analysis of their conservation level indicated that neither of the
ORFs showed enhanced conservation compared to the rest of the
exonic or even intronic sequences in BISPR (Figures S6A–D in
Supplementary Material). The ORFs lacked the Kozak consensus
sequence, and showed frequent presence of frameshift-inducing
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FIGURE 3 | Subcellular localization of BISPR before and after IFN
stimulation. (A) RT-qPCR assays for detection of BISPR performed on
RNA extracted from nuclear and cytoplasmic fractions obtained before
and after IFNα addition. Note the two Y axes. (B,C) Detection of level of
U99 snoRNA [(B), nuclear marker] and GAPDH [(C), cytoplasmic marker]
by RT-qPCR in subcellular fractions analyzed in panel (A). The presence of
a significant level of U99 in cytoplasmic fractions indicates the leakage of
nuclear RNAs into the cytoplasmic fraction preparation. (D) Polysome
profile analysis of BISPR. The top two panels show the position of the
ribosomal RNA and RNP complexes. The bottom three panels are
RT-qPCR assays to determine the level of GAPDH (top), BST2 (middle),
and BISPR (bottom) in each fraction, expressed as percentage of total
signal detected in all fractions combined. The number of fractions are
shown at the bottom.
small insertions and deletions at a frequency that was not different
from the adjacent, non-ORF sequences (Figures S6A–D in Sup-
plementary Material). Further, the sequence variations between
species resulted in a large ratio of non-synonymous to synony-
mous changes in ORFs, which indicated lack of conservation of
the sequence of the resulting peptides even among closely related
species (Figures S6A–D in Supplementary Material). To comple-
ment and experimentally confirm the computational analysis of
the protein-coding capacity of BISPR, we asked whether the cyto-
plasmic fraction of BISPR associated with polysomes. As can be
seen in Figure 3D, unlike GAPDH and BST2, which showed clear
enrichment in polysome fractions, the cytoplasmic BISPR RNA
showed a more or less uniform distribution across the sucrose
gradient, with reduced levels in heavier fractions. This pattern
indicates that the distribution of BISPR RNA is independent of
the location of ribosomal complexes in the gradient and is likely
governed by the set of proteins and other cellular factors that
associate with this RNA. Taken together, these results indicated
that BISRP was not likely to code for functional peptides and
thus, was a spliced and polyadenylated, long non-protein-coding
RNA.
BISPR IS INDUCED THROUGH IFN-MEDIATED ACTIVATION OF
JAK–STAT PATHWAY IN DIVERSE CELL TYPES
We could show that BISPR was a bona fide ISG as blocking the
JAK–STAT pathway by shRNAs against STAT2 or the use of JAK-
inhibitor ruxolitinib prevented its IFN-mediated up-regulation
(Figures 4A,B). BISPR was induced in response to both type I
and type II IFNs (IFNα and IFNγ, respectively), however, despite
the presence of NFkB binding sites on the shared BISPR–BST2
promoter, it did not show a transcriptional up-regulation after
treatment with TNFα (Figures 4C,D). Since BST2 is known to
mainly show antiviral activity against several viral families that
include retroviruses but neither of the major hepatotropic viruses
(36), we asked if IFN-mediated induction of BISPR could also
occur in cells involved in retroviral infections such as immune
cells. We could show that IFN stimulation of human THP1 mono-
cytic cells and Jurkat T cells resulted in induction of BISPR
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FIGURE 4 | Interferon-mediated induction of expression of BISPR occurs
through the JAK–STAT pathway. (A) RT-qPCR assays to measure the level
of STAT2 (left) and BISPR (right) to show the level of knock down of STAT2
and the level of induction of BISPR after IFN stimulation in STAT2 knock down
cells, respectively. The identity of the shRNA construct used in each sample is
shown below the graph. (B) Assays to determine the level of IFN-mediated
induction of BISPR (left) and BST2 (right) before and after treatment with the
JAK-inhibitor, ruxolitinib (Ruxo). Plus and minus signs indicate the added or
omitted ingredients. (C) BISPR RNA is induced in response to IFNγ
stimulation. (D) BISPR is not induced in response to TNFα stimulation (left),
while a known TNFα-responding ISG, CXCL10, is strongly induced as a result
of TNFα treatment (right).
(Figures 5A,C). In addition, we tested other cell types including
primary human keratinocytes and HeLa cells (cervical epithelium
origin) and observed that BISPR was induced in response to IFNα
in these cells (Figures 5B,D). These results suggested that the IFN-
mediated induction of BISPR expression was not restricted to a
certain cell type, but that the RNA was a general IFN-induced
factor. Importantly, analysis of IFN-induced BST2 expression in
parallel showed that the pattern of induction of BISPR showed
concordance with BST2 in all cell types tested (Figures 5A–D, see
also Figures 2A,B), confirming the coordinate regulation of the
two RNAs. To further analyze the correlation of expression of the
two RNAs in immune system-derived cells, we measured the level
of BISPR and BST2 in primary human NK and PBMC derived
from healthy human donors (Figure 5E). While the small number
of samples (n= 3 for NK cells and n= 2 for PBMC) prevents us
from deriving statistically significant conclusions from these data,
the level of BST2 and BISPR in both primary cells and the cell
lines studied above showed a modest correlation, with a Spear-
man’s correlation coefficient of 0.59 for both groups (Figure 5E).
Since THP1 cells represented a more physiologically relevant study
model than Huh7.5 hepatocytes for the study of function of BISPR,
all subsequent studies were performed in this cell line.
lncRNA BISPR IS A POSITIVE REGULATOR OF THE EXPRESSION OF BST2
As mentioned above, study of a number of lncRNA/protein-coding
RNA pairs resulting from bidirectional promoters has shown a role
for the lncRNAs in regulation of expression of their protein-coding
“twins.” To directly investigate this possibility in BST2/BISPR pair,
we knocked down the expression of BISPR using siRNAs. In
order to prevent the possibility of siRNA-mediated interference
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FIGURE 5 | BST2 IFN-stimulated positive regulator is induced in
diverse cell types in response to IFN and shows a concordant
expression pattern with BST2. (A–D)Time course of IFNα-mediated
induction of BISPR (left) and BST2 (right) in THP1 cells [monocyte origin,
(A)], primary human keratinocytes (B), Jurkat T cells (C), and HeLa cells
[cervical origin, (D)] measured by RT-qPCR. The identity of cells being
analyzed is shown on top. (E) Correlation of the level of BISPR and BST2
in the four cells lines shown in (A–D) (empty circles), and NK and PBMC
cells obtained from human donors (solid circles and squares,
respectively). Note the two sets of axes and trendlines, which mark the
values of samples of the corresponding color. Vertical and horizontal axes
correspond to BST2 and BISPR values, respectively. The Spearman
correlation coefficient for the entire sample group is shown at the bottom
right of the graph.
with the function of the enhancer or promoter elements, we
ensured that the siRNAs were designed against sequences in the
last two exons of BISPR and far from the promoter and the
enhancer regions (see Materials and Methods). Interestingly, siR-
NAs which reduced the level of BISPR also reduced the level of
BST2 (Figures 6A,B), suggesting that transcription of the BISPR
RNA is required for efficient transcription of BST2 mRNA. To
ensure that the observed down-regulation did not result from a
general transcriptional silencing of the locus, we measured the
expression level of MVB12A, which is located a short distance
downstream of BISPR and close to the region targeted by the siR-
NAs. However, the transcription of MVB12A showed no change in
siRNA-treated cells (Figure 6C, see also the BISPR overexpression
study below). To determine if any other ISGs beyond BST2 were
affected by BISPR knock down, we tested the expression level of
several other ISGs in siRNA-treated cells, which did not show sig-
nificant changes in response to siRNAs (Figures 6D–F). Thus,
knock down of BISPR seemed to result in specific down-regulation
of BST2.
We asked whether the observed reduction in the steady-state
level of BST2 mRNA resulted from modulation of transcription
of this RNA or a change in its stability. To this end, we blocked
transcription in siRNA-treated cells using actinomycin D treat-
ment and measured the level of BST2 mRNA at several time
points (Figure 6G). We observed a slower, rather than faster, decay
rate for BST2 mRNA in siRNA-treated cells, which indicated that
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FIGURE 6 | BISPR is a positive regulator of BST2 expression. (A–F)
RT-qPCR assays to determine the relative cellular level of transcripts shown
on top of each panel in THP1 cells treated with BISPR-targeting siRNAs
(DsiRNA #1 and #2) and control siRNA. Statistical analysis of the control
siRNA and BISPR-targeting siRNA groups yielded p-values <0.05 for panels A
and B. The differences between these groups in panels C through F were not
significant. (G)The relative level of BST2 (left) and GAPDH (right, analyzed as
control) are measured at several time points after the addition of actinomycin
D to block transcription in cells transfected with a control siRNA (data shown
in black) or BISPR-targeting siRNA (data shown in red). The level of BST2 or
GAPDH is measured at each time point using RT-qPCR assays. (H) BISPR
shows an earlier induction curve in response to IFNα stimulation compared to
BST2. The Y axis indicates the ratio of the level of BISPR to BST2 transcripts
(delta Ct) at each time point after IFN stimulation. (I) Early time points after
IFNα stimulation of THP1 cells confirm that the induction of expression of
BISPR precedes that of BST2. Cellular RNA has been extracted at the
indicated time points and analyzed in parallel to determine the level of BST2
and BISPR using RT-qPCR assays. (J) RT-qPCR measurement of the level of
BISPR and BST2 in THP1 cells stably overexpressing BISPR from a transgene.
+ Vector and + BISPR indicate cells stably transfected with a control, empty
vector or the BISPR construct, respectively. (K)The efficiency of
shRNA-mediated knock-down of EZH2 (left panel) and the level of BISPR and
BST2 in control and knock down THP1 cells (right panel) are shown, as
determined by RT-qPCR. + sh-NT and + sh-EZH2-1 and 2 indicate cells stably
transfected with a non-targeting shRNA or one of the two EZH2-targeting
shRNA constructs, respectively.
the reduced stability of BST2 mRNA was not responsible for the
lower level of BST2 mRNA in these cells. Thus, knock down of
BISPR resulted in transcriptional down-regulation of BST2. The
above results suggested that expression of BISPR was required
for the efficient transcription of BST2 locus and thus, this RNA
seemed to function as BST2 IFN-Stimulated Positive Regulatory
RNA (BISPR).
Interestingly, comparison of the time course of induction of
BISPR and BST2 in response to IFN indicated a faster rate of
induction of BISPR compared to BST2 in all tested cell types
(Figure 6H, compare Figures 5A–D). To further substantiate this
observation, we took early time points after IFN stimulation in
THP1 cells and monitored the level of BST2 and BISPR RNA in
parallel. Intriguingly, while BST2 did not show a significant induc-
tion until 90 min after IFN stimulation, the level of BISPR showed
a significant rise after only 40 min (Figure 6I), suggesting that
transcriptional activation of the locus is initiated by induction of
the expression of BISPR RNA. To further confirm this possibil-
ity, we forcefully overexpressed the fully spliced BISPR RNA from
a stably transfected construct under the control of the constitu-
tive CMV promoter (Figure 6J). Interestingly, overexpression of
BISPR from the transgene resulted in up-regulation of expression
of the endogenous BST2 gene (Figure 6J), indicating that BISPR
RNA itself, rather than the impact of its transcription from a locus
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adjacent to BST2, is responsible for regulation of expression of
BST2. As mentioned above, many lncRNAs are thought to act by
regulation of chromatin state through binding and recruitment
of various repressor or activator chromatin modifying factors
(e.g., PRC2 and WDR5, respectively) to their regulatory loci (7,
46) and it is possible to envision that upon IFN stimulation,
BISPR may act by recruiting an activator protein to its shared
locus with BST2 to counteract a constitutive repressive chromatin
state. As a first step toward investigating this possibility, we asked
whether the transcriptional activity of BISPR/BST2 locus under
basal, unstimulated conditions is regulated by one of the known
repressive chromatin modifying complexes. Using shRNAs target-
ing the methyltransferase component of PRC2, EZH2, we could
show that even a modest reduction in the level of EZH2 can
result in up-regulation of both BISPR and BST2 (Figure 6K).
While defining the mechanism of function of BISPR and identifi-
cation of its interacting factors require extensive work beyond the
scope of the current manuscript, these preliminary results suggest
that counteracting the repressive action of PRC2 at this locus can
be a potential mechanism through which BISPR can perform its
regulatory function.
DISCUSSION
We have shown that the expression of several IFN-induced protein-
coding genes show a strong correlation with a lncRNA gene
located in their vicinity. Analysis of one such lncRNA/protein-
coding RNA pair suggested that they originate from a bidirectional
promoter, thus explaining their coordinated regulation. Interest-
ingly, it has recently been shown that the presence of protein-
coding/lncRNA pairs resulting from bidirectional promoters is
frequently seen among transcriptionally regulated protein-coding
transcripts (25). This, in turn, raises the possibility that the pres-
ence of a promoter-sharing lncRNA provides additional means for
fine-turning the regulation of expression of such protein-coding
RNAs. Indeed, in some studied cases, the expression of protein
coding genes is regulated by their promoter-sharing lncRNA,
with RNAi-mediated knock down of the lncRNA resulting in up-
regulation of expression of the protein-coding gene (31, 32). Our
analysis of the BST2/BISPR pair provides a new example for such
regulation, albeit in the opposite direction, as knock down and
overexpression of BISPR led to transcriptional down- and up-
regulation of BST2, respectively, suggesting an activating role for
BISPR in regulation of BST2 expression.
While several studied lncRNAs have an activating impact on
their neighboring protein-coding genes (47, 48), divergent tran-
scription from a bidirectional promoter provides unique oppor-
tunities for regulation. Divergent transcription may induce local
chromatin remodeling, which may be a pre-requisite for the activa-
tion of the downstream gene, as has been shown for adjacent genes
(49). Also, divergent transcription can induce negative upstream
supercoiling of DNA and thus, promote upstream transcriptional
initiation (23). Further, the nascent or fully transcribed RNA may
recruit chromatin remodeling or transcriptional complexes to its
site of transcription and thereby influence the transcriptional
activity of the locus (50, 51). We have shown that in the case
of BISPR/BST2 pair, expression of BISPR is the first to be induced
by activating stimuli, and importantly, that forced overexpression
of BISPR from a transgene (which is unlikely to be integrated
close to the locus of the endogenous BISPR/BST2 pair in all over-
expression clones tested) results in up-regulation of BST2. These
results strongly point to the third scenario described above, in
which the mature transcribed lncRNA mediates the recruitment
of chromatin modifying factors or activating transcriptional com-
plexes to its site of transcription, however, the other two, cis-acting
mechanisms described above may also contribute to the regulatory
function of BISPR.
As mentioned before, analysis of chromatin modification pat-
terns suggests that the BISPR/BST2 locus overlaps an enhancer
region. It is known that many, if not all, enhancers are bidirection-
ally transcribed into functionally required enhancer-associated
RNAs (eRNAs) (52–54). It has been proposed that either the
eRNA transcripts themselves or the act of transcription con-
tributes to the function of enhancers (55). While the efficient
formation of the enhancer–promoter contact is thought to require
the interaction of eRNAs with the mediator complex and cohesin
(45, 55), eRNAs may help establish chromatin accessibility, thus
enhancing transcription (56). Based on the existing literature,
however, the majority of eRNAs are much shorter than BISPR
and BST2, and are not spliced or polyadenylated (52–54). In
cases where eRNAs were polyadenylated, they were transcribed
uni-directionally rather than bidirectionally. While BISPR is cer-
tainly not a classical eRNA, it is perceivable that it may also
participate in regulation of expression of hitherto un-identified
distant target genes as an eRNA. There is also the remote, but
nonetheless existing, possibility that the BISPR/BST2 pair may
have evolved from an ancestral bidirectional enhancer-associated
promoter and transcription of either of the RNAs may affect the
ability of the enhancer to regulate any distant targets that it may
have. Interestingly, an example of bidirectional lncRNA/protein-
coding RNA transcription originating in an enhancer has recently
been described, in which the transcription of the lncRNA and
the ability of the enhancer to induce transcription in a down-
stream gene seemed to be coordinated (57). Taken together,
these findings provide a novel example of stable bidirectional
transcription from transcribed enhancer loci and point to the
presence of RNA-mediated regulatory networks involving bidi-
rectionally transcribed lncRNA/protein-coding RNA pairs. Con-
sidering the abundance of lncRNA/protein-coding RNA pairs
originating from bidirectional promoters in the human genome,
it is possible that the lncRNA-mediated transcriptional regulation
described in this work contributes to the regulation of expression
of additional protein-coding genes in the IFN response and other
cellular processes.
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